Penn I.Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet1986; 162: 603-10.
2.
Kay S., Frable WJ, Hune DMCervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer1970 ; 26: 1048-52.
3.
Schneider V. , Kay S., Lee KMImmunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix . Acta Cytol1983; 27: 220-4.
4.
Schafer A., Friedman W., Mielke M., Schwartlander B., Koch MAThe increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression . Am J Obstet. Gynecol1991; 164: 593-9.
5.
Hartveit F., Bertelsen B., Thunold S., Maehle BO, Skaarland E., Christenesen J.Risk of cervical intraepithelial neoplasia in women with glomerulonephritis . Br Med J1991; 302: 375-7.
6.
Lewis RB, Castor W., Knisley RE, Bole GGFrequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis . Arth Rheum1976; 19: 1256-60.
7.
Nybertg G., Eriksson O., Westberg NGIncreased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arth Rheum1981 ; 24: 648-50.
8.
Blumenfeld Z. , Lorber M., Yoffe N., Scharf Y.Systemic lupus erythematosus - a predisposition for uterine cervical dysplasia. Lupus1994 ; 3: 59-61.
9.
Zur Hausen H.Human genital cancer: synergism between two virus infections or synergism between a virus infection and an initiating agent? Lancet1982; ii: 1370-2.
10.
Lane DP, Crawford LVT antigen is bound to a host protein in SV40-transformed cells. Nature1979; 278: 261-3.
11.
Eliyahu D., Goldfinger N., Pinhasi Kimhi O. et al. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene1988; 3: 313-21.
12.
Eustace D., Han X., Gooding R., Rowbottom A., Riches P., Heyderman E.Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas an vitro. Gynecol Oncol1993; 50: 15-19.
13.
Yoshizaki K. , Nishimoto N., Matsumoto K. et al. Interleukin 6 and expression of its receptor on epidermal keratinocytes. Cytokine1990; 2: 381-7.
14.
Santhanam U. , Ray A., Sehgal PBRepression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci (USA)1991; 88: 7605-9.
15.
Linker-Israeli M., Deans RJ, Wallace DJ, Prehn J., Ozeri-Chen T., Klinenberg JRElevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol1991; 147: 117-23.
